UnitedHealth Group has entered into an agreement to sell its operations in Brazil to a private investor. Upon closing the Company expects to record a charge of approximately $7 billion, which will be excluded from adjusted earnings, the majority of which is non-cash and due to the cumulative impact of foreign currency translation losses. In connection with the action, the Company’s 2024 net earnings outlook will be impacted by the expected charge.